A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
Clinical trial NCT02694978 · COMPLETED
Trial details
- NCT number
- NCT02694978
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2017-01-16
- Enrollment
- 2014
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.